Improving Participant Recruitment in Clinical Trials
Author Information
Author(s): Mavragani Amaryllis, Chien Patrick F. W, Popovic Martin, Howe Nicola, Bikou Alexia Georgia MSc, Deligianni Elena MSc, Dermiki-Gkana Foteini MSc, Liappas Nikolaos PhD, Teriús-Padrón José Gabriel PhD, Beltrán Jaunsarás Maria Eugenia PhD, Cabrera-Umpiérrez Maria Fernanda PhD, Kontogiorgis Christos PhD
Primary Institution: Democritus University of Thrace
Hypothesis
This study aims to investigate the use of novel digital platforms and their features to optimize and expedite clinical research.
Conclusion
The study highlights the vital role of digital platforms in clinical trials, aiding in recruitment and enhancing patient engagement.
Supporting Evidence
- 80% of clinical trials face delays due to patient recruitment issues.
- 80% of the identified platforms are based in the United States.
- 60% of the platforms incorporate electronic consent features.
- Many platforms have seen increased adoption following the COVID-19 outbreak.
Takeaway
This study looks at new digital tools that help find and enroll people in clinical trials faster and easier.
Methodology
A systematic review of literature from January 2000 to October 2024 was conducted using various databases to identify relevant studies.
Potential Biases
Potential biases may arise from the reliance on digital tools that may not be accessible to all populations.
Limitations
Challenges in accessibility, compatibility, and transparency of digital tools were noted.
Participant Demographics
Most platforms are headquartered in the United States, with a focus on diverse patient populations.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website